NCT02089113 OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery Status COMPLETED Phase PHASE3
NCT02086942 Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma. Status UNKNOWN Phase PHASE2
NCT02082405 Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT02076009 A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT02073734 Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP Status COMPLETED Phase PHASE3
NCT02062905 OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Status COMPLETED Phase PHASE2
NCT02061631 Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck Status COMPLETED Phase PHASE2
NCT02057640 MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT02057380 A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial Status COMPLETED Phase PHASE2
NCT02056379 Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on Children Status UNKNOWN Phase NA
NCT02047253 Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment Status COMPLETED Phase PHASE2
NCT02046915 Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide Status COMPLETED Phase PHASE2
NCT02046070 Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02036502 A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023) Status TERMINATED Phase PHASE1
NCT02034019 Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery Status COMPLETED Phase PHASE3
NCT02031965 Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery Status TERMINATED Phase PHASE1